1. Acute pancreatitis: recent advances through randomised trials
- Author
-
Harry van Goor, Paul Fockens, Sven M. van Dijk, Nora D L Hallensleben, Marc G. Besselink, Marco J. Bruno, Hjalmar C. van Santvoort, Surgery, Gastroenterology & Hepatology, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, Gastroenterology and Hepatology, Other departments, and APH - Methodology
- Subjects
medicine.medical_specialty ,Aftercare ,Severity of Illness Index ,03 medical and health sciences ,0302 clinical medicine ,Recurrence ,Severity of illness ,Secondary Prevention ,medicine ,Humans ,Combined Modality Therapy ,Intensive care medicine ,Randomized Controlled Trials as Topic ,Secondary prevention ,business.industry ,Incidence (epidemiology) ,Gastroenterology ,Prognosis ,medicine.disease ,Reconstructive and regenerative medicine Radboud Institute for Molecular Life Sciences [Radboudumc 10] ,Pancreatitis ,030220 oncology & carcinogenesis ,Acute Disease ,Acute pancreatitis ,030211 gastroenterology & hepatology ,business - Abstract
Contains fulltext : 177888.pdf (Publisher’s version ) (Closed access) Acute pancreatitis is one of the most common GI conditions requiring acute hospitalisation and has a rising incidence. In recent years, important insights on the management of acute pancreatitis have been obtained through numerous randomised controlled trials. Based on this evidence, the treatment of acute pancreatitis has gradually developed towards a tailored, multidisciplinary effort, with distinctive roles for gastroenterologists, radiologists and surgeons. This review summarises how to diagnose, classify and manage patients with acute pancreatitis, emphasising the evidence obtained through randomised controlled trials.
- Published
- 2017
- Full Text
- View/download PDF